This section has no associated Explanatory Memorandum
33. Where and in so far as the licence relates to special medicinal products, the licence holder may only import such products from [F1, in the case of an import into Great Britain, an approved country for import and in the case of an import into Northern Ireland, an EEA State]—U.K.
(a)in response to an order which satisfies the requirements of regulation 167, and
(b)where the conditions set out in paragraphs 34 to 41 are complied with.
Textual Amendments
F1Words in Sch. 4 para. 33 substituted (31.12.2020) by S.I. 2019/775, reg. 20(6) (as substituted by The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020 (S.I. 2020/1488), reg. 1, Sch. 2 para. 14(e))